NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 262 filers reported holding NEKTAR THERAPEUTICS in Q2 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $10,000 | -89.4% | 3,017 | -42.5% | 0.00% | -100.0% |
Q3 2021 | $94,000 | -65.4% | 5,248 | -66.9% | 0.00% | -66.7% |
Q2 2021 | $272,000 | +13500.0% | 15,849 | +11553.7% | 0.01% | – |
Q4 2020 | $2,000 | -99.6% | 136 | -99.4% | 0.00% | -100.0% |
Q2 2020 | $489,000 | +270.5% | 21,131 | +192.6% | 0.05% | +42.1% |
Q3 2019 | $132,000 | +1785.7% | 7,222 | +3212.8% | 0.04% | +1166.7% |
Q1 2019 | $7,000 | -30.0% | 218 | +36.2% | 0.00% | 0.0% |
Q3 2018 | $10,000 | -52.4% | 160 | -18.4% | 0.00% | -72.7% |
Q1 2018 | $21,000 | +200.0% | 196 | -51.0% | 0.01% | +175.0% |
Q3 2016 | $7,000 | – | 400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Strong Tower Advisory Services | 404,972 | $6,913,000 | 4.02% |
GREAT POINT PARTNERS LLC | 504,691 | $9,064,000 | 2.11% |
Camber Capital Management LP | 3,750,000 | $67,350,000 | 2.07% |
ACT CAPITAL MANAGEMENT, LLC | 161,500 | $2,901,000 | 1.50% |
Rhenman & Partners Asset Management AB | 950,000 | $17,062,000 | 1.20% |
MAVERICK CAPITAL LTD | 5,838,426 | $104,858,000 | 1.06% |
Birchview Capital, LP | 72,000 | $1,293,000 | 0.88% |
Bellevue Group AG | 4,594,656 | $82,519,000 | 0.84% |
CM Management, LLC | 50,000 | $898,000 | 0.67% |
Duquesne Family Office | 1,000,000 | $17,960,000 | 0.58% |